Changes in the Gut Microbiome Associated with Intussusception in Patients with Peutz-Jeghers Syndrome
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Peutz-Jeghers Polyp Peutz Jeghers polyp,Peutz-Jeghers polyp,Peutz-Jeghers Polyp,peutz-Jeghers Polyp
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- healthy control (family members)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Peutz-Jeghers syndrome (PJS)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients who has Peutz-Jeghers syndrome (PJS)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 68
- Group 1 sample size Number of subjects in the case (exposed) group
- 168
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- within 3 months
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- LEfSe
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 3.0
Alpha Diversity
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Source: FIG 1 (F)
Description: LEfSe analysis identified the differentially abundant taxa between Peutz-Jeghers syndrome (PJS) patients and healthy controls (LDA > 3.0)
Abundance in Group 1: increased abundance in Peutz-Jeghers syndrome (PJS)
Revision editor(s): Rahila, Scholastica
Signature 2
Source: FIG 1 (F)
Description: LEfSe analysis identified the differentially abundant taxa between Peutz-Jeghers syndrome (PJS) patients and healthy controls (LDA > 3.0)
Abundance in Group 1: decreased abundance in Peutz-Jeghers syndrome (PJS)
Revision editor(s): Scholastica
Experiment 2
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Without Intussusception (NI-PJS)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- With Intussusception (I-PJS)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients who had undergone at least one intussusception (I-PJS)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 57
- Group 1 sample size Number of subjects in the case (exposed) group
- 106
Lab analysis
Statistical Analysis
Alpha Diversity
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Source: FIG 2 (D)
Description: LEfSe analysis identified the differences in abundance between I-PJS and NI-PJS patients (LDA > 3.0).
Abundance in Group 1: decreased abundance in With Intussusception (I-PJS)
Revision editor(s): Rahila
Signature 2
Source: FIG 2 (D)
Description: LEfSe analysis identified the differences in abundance between I-PJS and NI-PJS patients (LDA > 3.0).
Abundance in Group 1: increased abundance in With Intussusception (I-PJS)
Revision editor(s): Rahila
Experiment 3
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- healthy control (family members)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Peutz-Jeghers syndrome (PJS)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients who has Peutz-Jeghers syndrome (PJS)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 27
- Group 1 sample size Number of subjects in the case (exposed) group
- 61
Lab analysis
- Sequencing type
- WMS
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- Not specified
Statistical Analysis
- Statistical test
- LEfSe
- Mann-Whitney (Wilcoxon)
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 2.0
Signature 1
Source: FIG 3 (D)
Description: LEfSe analysis identified the differential species between Peutz-Jeghers syndrome (PJS) patients and healthy controls (LDA > 2.0)
Abundance in Group 1: increased abundance in Peutz-Jeghers syndrome (PJS)
Revision editor(s): Rahila, Scholastica
Signature 2
Source: FIG 3 (D)
Description: LEfSe analysis identified the differential species between Peutz-Jeghers syndrome (PJS) patients and healthy controls (LDA > 2.0)
Abundance in Group 1: decreased abundance in Peutz-Jeghers syndrome (PJS)
Revision editor(s): Scholastica
Experiment 4
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Without Intussusception (NI-PJS)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- With Intussusception (I-PJS)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients who had undergone at least one intussusception (I-PJS)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 26
- Group 1 sample size Number of subjects in the case (exposed) group
- 35
Lab analysis
Statistical Analysis
Signature 1
Source: FIG 4 (D)
Description: LEfSe analysis showed the differential species between I-PJS and NI-PJS patients (LDA > 2.0).
Abundance in Group 1: increased abundance in With Intussusception (I-PJS)
NCBI | Quality Control | Links |
---|---|---|
Aeromonas veronii | ||
Collinsella sp. AF08-23 | ||
Dialister invisus CAG:218 | ||
Fusobacterium necrogenes | ||
Fusobacterium sp. | ||
unclassified Aeromonas | ||
bacterium 1xD8-27 |
Revision editor(s): Rahila
Signature 2
Source: FIG 4 (D)
Description: LEfSe analysis showed the differential species between I-PJS and NI-PJS patients (LDA > 2.0).
Abundance in Group 1: decreased abundance in With Intussusception (I-PJS)
Revision editor(s): Rahila